Nicox (NICXF) Operating Cash Flow per Share : $-0.45 (TTM As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Nicox Operating Cash Flow per Share?

Nicox's operating cash flow per share for the six months ended in Jun. 2023 was $-0.18. Nicox's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.45.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 0.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 3.80% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 12.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Nicox's Operating Cash Flow per Share or its related term are showing as below:

NICXF' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -866.6 Med: 0.3 Max: 49.5
Current: 0.3

During the past 13 years, Nicox's highest 3-Year average Operating Cash Flow per Share Growth Rate was 49.50% per year. The lowest was -866.60% per year. And the median was 0.30% per year.

NICXF's 3-Year OCF Growth Rate is ranked worse than
55.23% of 1242 companies
in the Biotechnology industry
Industry Median: 3.6 vs NICXF: 0.30

Nicox Operating Cash Flow per Share Historical Data

The historical data trend for Nicox's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nicox Operating Cash Flow per Share Chart

Nicox Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.74

-0.59

-0.20

-0.56

Nicox Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.34	-0.21	-0.25	-0.27	-0.18

Competitive Comparison of Nicox's Operating Cash Flow per Share

For the Biotechnology subindustry, Nicox's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nicox's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nicox's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Nicox's Price-to-Operating-Cash-Flow falls into.

Nicox Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Nicox's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )	=	Cash Flow from Operations (A: Dec. 2022 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2022 )
	=	-24.497	/	43.972
	=	-0.56

Nicox's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Jun. 2023 )	=	Cash Flow from Operations (Q: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2023 )
	=	-9.018	/	50.146
	=	-0.18

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.45

Nicox Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Nicox's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Nicox (NICXF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nicox SA (OTCPK:NICXF) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

ALCOX:France NXOA:Germany

Address

2405 route des Dolines, Drakkar 2 -Batiment D, Valbonne, Sophia Antipolis, FRA, 06560

Website

https://www.nicox.com

Nicox SA is an international company specializing in ophthalmology developing solutions aimed at maintaining vision and improving eye health. Nicox's program in clinical development is NCX 470, a novel nitric oxide-donating prostaglandin analog for the reduction of intraocular pressure in patients with glaucoma or ocular hypertension. It is also conducting research on NCX 1728, a NO-donating phosphodiesterase 5 inhibitor, in retinal diseases. NCX 4251, a patented ophthalmic suspension of fluticasone propionate nanocrystals, for topical ocular application for dry eye, is being developed by Ocumension Therapeutics in China. Nicox generates revenue from VYZULTA in glaucoma and ZERVIATE in allergic conjunctivitis.

Nicox (NICXF) Headlines

From GuruFocus

Bausch Health Announces VYZULTA� (latanoprostene bunod ophthalmic solution), 0.024%, is Now Approved in South Korea

By PRNewswire PRNewswire • 02-09-2021